206 related articles for article (PubMed ID: 2670487)
41. The effect of terminal ileal triglyceride infusion on gastroduodenal motility and the intragastric distribution of a solid meal.
Fone DR; Horowitz M; Read NW; Dent J; Maddox A
Gastroenterology; 1990 Mar; 98(3):568-75. PubMed ID: 2298363
[TBL] [Abstract][Full Text] [Related]
42. Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs.
Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
Dig Dis Sci; 1999 Jun; 44(6):1100-6. PubMed ID: 10389679
[TBL] [Abstract][Full Text] [Related]
43. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
44. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
[TBL] [Abstract][Full Text] [Related]
45. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
46. Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretion.
Dubrasquet JM; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():257-9. PubMed ID: 2875447
[TBL] [Abstract][Full Text] [Related]
47. Effect of ethanol ingestion on postprandial gastric emptying and secretion, biliopancreatic secretions, and duodenal absorption in man.
Jian R; Cortot A; Ducrot F; Jobin G; Chayvialle JA; Modigliani R
Dig Dis Sci; 1986 Jun; 31(6):604-14. PubMed ID: 3709325
[TBL] [Abstract][Full Text] [Related]
48. [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].
Depigny C; Lupo B; Kervran A; Bataille D
C R Acad Sci III; 1984; 299(16):677-80. PubMed ID: 6097350
[TBL] [Abstract][Full Text] [Related]
49. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
50. Relation between fasting antroduodenal motility and transpyloric fluid movements.
Schindlbeck NE; Heinrich C; Müller-Lissner SA
Am J Physiol; 1989 Aug; 257(2 Pt 1):G198-201. PubMed ID: 2764107
[TBL] [Abstract][Full Text] [Related]
51. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
[TBL] [Abstract][Full Text] [Related]
52. N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Rolland M; Bataille D
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):57-63. PubMed ID: 1538791
[TBL] [Abstract][Full Text] [Related]
53. Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function.
Hotz J; Ho SB; Go VL; DiMagno EP
J Lab Clin Med; 1983 Mar; 101(3):488-95. PubMed ID: 6186758
[TBL] [Abstract][Full Text] [Related]
54. Radionuclide studies on gastric evacuatory function in health and in the duodenal ulcer disease. I. Types of solid meal distribution within the stomach and their relation to gastric emptying.
Jonderko K
Nucl Med Commun; 1987 Aug; 8(8):671-80. PubMed ID: 3320833
[TBL] [Abstract][Full Text] [Related]
55. Intraileal carbohydrate regulates canine postprandial pancreaticobiliary secretion and upper gut motility.
Tohno H; Sarr MG; DiMagno EP
Gastroenterology; 1995 Dec; 109(6):1977-85. PubMed ID: 7498664
[TBL] [Abstract][Full Text] [Related]
56. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
[TBL] [Abstract][Full Text] [Related]
57. Colonic fermentation and proximal gastric tone in humans.
Ropert A; Cherbut C; Rozé C; Le Quellec A; Holst JJ; Fu-Cheng X; Bruley des Varannes S; Galmiche JP
Gastroenterology; 1996 Aug; 111(2):289-96. PubMed ID: 8690193
[TBL] [Abstract][Full Text] [Related]
58. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
59. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.
Layer P; Holst JJ; Grandt D; Goebell H
Dig Dis Sci; 1995 May; 40(5):1074-82. PubMed ID: 7729267
[TBL] [Abstract][Full Text] [Related]
60. [Peptic ulcer and intestinal hormones].
Geller LI
Klin Med (Mosk); 1986 Apr; 64(4):32-7. PubMed ID: 2873268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]